論文

査読有り
2021年9月

Distribution of serum adiponectin isoforms in pediatric patients with steroid-sensitive nephrotic syndrome.

Clinical and experimental nephrology
  • Tetsuro Tamai
  • Kaori Kamijo
  • Yoshifusa Abe
  • Satoshi Hibino
  • Shunsuke Sakurai
  • Shuichiro Watanabe
  • Yoshitaka Watanabe
  • Satomi Nimura
  • Atsutoshi Shiratori
  • Takaaki Takayanagi
  • Tsuneki Watanabe
  • Yuya Nakano
  • Hirokazu Ikeda
  • Kazushige Dobashi
  • Yasuko Nakano
  • Katsumi Mizuno
  • Kazuo Itabashi
  • 全て表示

25
9
開始ページ
1027
終了ページ
1034
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1007/s10157-021-02085-w

BACKGROUND: Serum adiponectin circulates in three multimeric isoforms: high-molecular-weight (HMW), middle-molecular-weight (MMW), and low-molecular-weight (LMW) isoforms. Potential change in the circulating adiponectin levels in patients with nephrotic syndrome (NS) remain unknown. This study aimed to assess the levels of total adiponectin and the distribution of its isoforms in pediatric patients with NS. METHODS: We sequentially measured total adiponectin and each adiponectin isoform levels at the onset of NS, initial remission, and during the remission period of the disease in 31 NS patients. We also calculated the ratios of HMW (%HMW), MMW (%MMW), and LMW (%LMW) to total adiponectin incuding 51 control subjects. RESULTS: The median of total serum adiponectin levels in patients were 36.7, 36.7, and 20.2 μg/mL at the onset, at initial remission, and during the remission period of NS, respectively. These values were significantly higher than those in control subjects. The median values of %HMW, %MMW, and %LMW values were 56.9/27.0/14.1 at the onset, 62.0/21.8/13.4 at the initial remission, and 58.1/21.7/17.5 at during the remission period of NS, respectively. Compared with control subjects, %HMW at initial remission and %MMW at the onset were high, and the %LMW values at the onset and at initial remission were low. CONCLUSIONS: In patients with NS, total serum adiponectin levels increase at the onset of the disease, and the ratio of adiponectin isoforms changes during the course of the disease. Further studies are needed to delineate the mechanisms between proteinuria and adiponectin isoforms change.

リンク情報
DOI
https://doi.org/10.1007/s10157-021-02085-w
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/34061287
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357647
ID情報
  • DOI : 10.1007/s10157-021-02085-w
  • PubMed ID : 34061287
  • PubMed Central 記事ID : PMC8357647

エクスポート
BibTeX RIS